Recently, C-type lectin domain family 14 member A (CLEC14A) has been identified as part of a molecular gene signature for tumor angiogenesis based on a meta-analysis on breast cancer, head and neck squamous cell carcinoma (HNSCC), and clear-cell renal cell carcinoma (ccRCC) (115). The gene discussed is CLEC14A; the disease is breast cancer.